Physician profile
Kapil Moza
NPI 1841231248
$11,393.64
in general payments reported to CMS, 2019-2025
30 companies · $2,795 in 2025
The $2,795 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,779 · 2020: $617 · 2021: $1,976 · 2022: $1,803 · 2023: $1,002 · 2024: $1,422 · 2025: $2,795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,218.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $2,920.52 | 2019-2025 | Corridor, Acp, Modulus |
| Abbott Laboratories | $2,547.91 | 2019-2025 | Eterna, Lamitrode Tripole, Proclaim |
| Nuvasive, INC. | $1,208.21 | 2021-2023 | Pulse, Attrax, Acp |
| Depuy Synthes Sales INC. | $1,021.44 | 2019-2022 | |
| Alphatec Spine, INC | $853.30 | 2021-2022 | |
| Stimwave Technologies Incorporated | $282.38 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $278.64 | 2019-2021 | |
| Lilly USA, LLC | $213.57 | 2019 | |
| Centinel Spine, LLC | $200.68 | 2024-2025 | Prodisc C Vivo |
| Boston Scientific Corporation | $173.11 | 2019 | |
| Stryker Corporation | $173.08 | 2024 | Zip Ds Dressing Shield |
| Nevro Corp. | $159.06 | 2020-2022 | |
| Medtronic USA, INC. | $152.64 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $147.56 | 2025 | |
| Highridge Medical LLC | $146.03 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clariance, INC. | $138.31 | 2023 | Idys-C Zp 3dti |
| Ossdsign USA Incorporated | $134.71 | 2024 | |
| Nexxt Spine LLC | $119.45 | 2019-2020 | |
| Kerecis Limited | $63.99 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Medline Industries Lp | $61.43 | 2019 | |
| Amplify Surgical, INC. | $57.15 | 2021 | |
| Axogen | $54.29 | 2021-2022 | |
| Surgalign Spine Technologies, INC. | $50.88 | 2019-2021 | |
| Ctl Medical Corporation | $50.00 | 2022 | |
| Spineology INC. | $48.45 | 2019 | |
| Assertio Therapeutics, INC. | $45.31 | 2020 | |
| Zimvie INC. | $25.69 | 2022 | |
| Ethicon US, LLC | $24.43 | 2021 | |
| Medtronic, INC. | $21.80 | 2021 | |
| Arteriocyte Medical Systems, INC. | $19.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kapil Moza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.